603669 Stock Overview
Lionco Pharmaceutical Group Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells pharmaceuticals in China. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Lionco Pharmaceutical Group Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥6.08 |
| 52 Week High | CN¥7.15 |
| 52 Week Low | CN¥2.94 |
| Beta | 0.25 |
| 11 Month Change | 46.51% |
| 3 Month Change | 37.25% |
| 1 Year Change | 5.92% |
| 33 Year Change | -27.19% |
| 5 Year Change | 20.40% |
| Change since IPO | -0.99% |
Recent News & Updates
Subdued Growth No Barrier To Lionco Pharmaceutical Group Co.,Ltd. (SHSE:603669) With Shares Advancing 30%
Nov 06
Lionco Pharmaceutical GroupLtd (SHSE:603669) Has Debt But No Earnings; Should You Worry?
Oct 29Recent updates
Subdued Growth No Barrier To Lionco Pharmaceutical Group Co.,Ltd. (SHSE:603669) With Shares Advancing 30%
Nov 06Lionco Pharmaceutical GroupLtd (SHSE:603669) Has Debt But No Earnings; Should You Worry?
Oct 29Lionco Pharmaceutical Group Co.,Ltd. (SHSE:603669) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected
May 10There's Reason For Concern Over Lionco Pharmaceutical Group Co.,Ltd.'s (SHSE:603669) Massive 28% Price Jump
Mar 12Shareholder Returns
| 603669 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -10.9% | -4.0% | -3.9% |
| 1Y | 5.9% | -5.3% | 4.0% |
Return vs Industry: 603669 exceeded the CN Pharmaceuticals industry which returned -5.3% over the past year.
Return vs Market: 603669 exceeded the CN Market which returned 4% over the past year.
Price Volatility
| 603669 volatility | |
|---|---|
| 603669 Average Weekly Movement | 7.4% |
| Pharmaceuticals Industry Average Movement | 7.2% |
| Market Average Movement | 8.1% |
| 10% most volatile stocks in CN Market | 12.4% |
| 10% least volatile stocks in CN Market | 5.5% |
Stable Share Price: 603669 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 603669's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | 475 | Ling Ping Tao | www.lingkang.com.cn |
Lionco Pharmaceutical Group Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells pharmaceuticals in China. The company offers nutrition, antimicrobial, antiviral, digestion, cardiovascular, detoxification, anti-tumor, and other products. Lionco Pharmaceutical Group Co., Ltd.
Lionco Pharmaceutical Group Co.,Ltd. Fundamentals Summary
| 603669 fundamental statistics | |
|---|---|
| Market cap | CN¥4.28b |
| Earnings (TTM) | -CN¥101.80m |
| Revenue (TTM) | CN¥277.20m |
15.4x
P/S Ratio-42.0x
P/E RatioIs 603669 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 603669 income statement (TTM) | |
|---|---|
| Revenue | CN¥277.20m |
| Cost of Revenue | CN¥162.18m |
| Gross Profit | CN¥115.02m |
| Other Expenses | CN¥216.82m |
| Earnings | -CN¥101.80m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.14 |
| Gross Margin | 41.49% |
| Net Profit Margin | -36.73% |
| Debt/Equity Ratio | 30.3% |
How did 603669 perform over the long term?
See historical performance and comparison